Literature DB >> 2873457

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients.

R K Woodruff, A P Grigg, F C Firkin, I L Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873457     DOI： 10.1016/s0140-6736(86)92511-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 2.  Current concepts in the treatment of immune thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 3.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

4.  Intravenous IgG: A New Therapeutic Tool.

Authors:  L K Boshkov; J G Kelton
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

5.  Intravenous immunoglobulin-related thromboembolic events - an accusation that proves the opposite.

Authors:  M Basta
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

6.  Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis.

Authors:  F A Bonilla
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 7.  Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Authors:  Jan D Lünemann; Falk Nimmerjahn; Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2015-01-06       Impact factor: 42.937

8.  [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors:  Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal:  Wien Klin Wochenschr       Date:  2012-03-03       Impact factor: 1.704

Review 9.  Immunoglobulin therapy in immunohematological disorders.

Authors:  V P Choudhry; M Mahapatra; R Kashyap
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

Review 10.  Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.

Authors:  P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.